Last edition
News about
AstraZeneca to Buy China-Based Gracell Biotechnologies in USD 1.2 Billion Deal
The cash deal aimed at bolstering AstraZeneca's portfolio values US listed Gracell at $2 per ordinary share or USD 10 per ADS of Gracell, plus a non-tradable contingent value right of USD 0.30 per ordinary share, if certain regulatory milestones are met.
Four Workers Hospitalised After Inhaling Toxic Gas at Pharma Chemical Factory
Four workers were hospitalised after they inhaled toxic gas leaking from a pipe at a pharmaceutical chemical company in Vadodara city of Gujarat, police said.
USFDA Inspects Aurobindo Pharma's New Jersey-Based Facility,Issues 10 Observations
The United States Food and Drug Administration (USFDA) issued 10 observations after conducting a pre-approval inspection at a facility linked to wholly-owned arm of Aurobindo Pharma in New Jersey
Zydus Lifesciences Receives 6 Observations from USFDA for API Site at Changodar
The inspection closed with 6 observations. There were no Data Integrity related observations. There are no repeat observations from the previous inspection.
AstraZeneca and Ionis' Wainua Granted First-Ever Regulatory Approval in US
AstraZeneca and Ionis’ Wainua (eplontersen) has been approved in the US for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults, commonly referred to as hATTR-PN or ATTRv-PN. Wainua is the only approved medicine for the treatment of ATTRv-PN that can be self-administered via an auto-injector.
Thermo Fisher Scientific Announces Launch of Innovative CorEvitas Pharmacovigilance Platform
Thermo Fisher Scientific Inc. announced the launch of CorEvidence, a proprietary cloud-based data lake platform optimizing pharmacovigilance case processing and safety data management processes.
Natco Pharma Ltd and Breckenridge Dismissed from Antitrust Lawsuit
The plaintiffs voluntarily dismissed Breckenridge Pharmaceutical Inc. and Natco Pharma Limited from the case.
Venus Remedies Achieves Marketing Authorizations for Docetaxel in Israel and Cytarabine in Colombia
Venus Remedies announce dual achievements in securing marketing authorisations for three variants of Docetaxel in Israel and Cytarabjne 100MG in Colombia.
Bain Capital-Backed Emcure Pharma Files Fresh IPO Papers with Sebi
Bain Capital-backed Emcure Pharmaceuticals has filed fresh preliminary papers with capital markets regulator Sebi to raise funds through an Initial Public Offering (IPO).
Tower Cold Chain Partnership Unveiled in China
Tower Cold Chain has reinforced its global availability by partnering with a Shanghai-based organisation, Tower & Winner Solutions (TWS), to drive the growth of Tower’s temperature-controlled passive containers across the Chinese market.
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy